早期识别与干预慢性肾脏病的必要性:KDIGO争议会议结论
慢性肾脏病(CKD)导致全球显著疾病负担并增加心血管及全因死亡。2019年KDIGO召开争议会议,探讨早期CKD的筛查、风险分层和治疗策略及健康系统与经济因素。共识认为应立即对高危人群实施CKD筛查联合风险分层和治疗,理想在初级或社区医疗环境中进行并因地制宜。
要点
- CKD筛查应联合风险分层和治疗立即用于高危人群。
- 筛查理想在初级或社区医疗环境中实施并因地制宜。
- 早期识别和治疗CKD是健康公平的必然要求。
核心结论
- CKD筛查联合风险分层和治疗应立即对高危人群实施,理想在初级或社区医疗环境中因地制宜进行。
研究设计与样本
- 2019年KDIGO争议会议,参与者识别早期CKD筛查、风险分层和治疗策略及实施的关键健康系统与经济因素。
主要发现
- CKD导致全球显著疾病负担并增加心血管和全因死亡。
- CKD负担不成比例地落在社会经济地位较低人群中,其CKD患病率更高、治疗可及性有限且结局更差。
- 缺乏关于健康系统和政府是否应优先早期识别和干预CKD的共识,且早期CKD指南在缺乏激励或质量措施时未普遍采用。
临床怎么用
- 对高危人群立即实施CKD筛查联合风险分层和治疗。
- 筛查和治疗最好在初级或社区医疗环境中进行并因地制宜。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic kidney disease (CKD) causes substantial global morbidity and increases cardiovascular and all-cause mortality. Unlike other chronic diseases with established strategies for screening, there has been no consensus on whether health systems and governments should prioritize early identification and intervention for CKD. Guidelines on evaluating and managing early CKD are available but have not been universally adopted in the absence of incentives or quality measures for prioritizing CKD care. The burden of CKD falls disproportionately upon persons with lower socioeconomic status, who have a higher prevalence of CKD, limited access to treatment, and poorer outcomes. Therefore, identifying and treating CKD at the earliest stages is an equity imperative. In 2019, Kidney Disease: Improving Global Outcomes (KDIGO) held a controversies conference entitled "Early Identification and Intervention in CKD." Participants identified strategies for screening, risk stratification, and treatment for early CKD and the key health system and economic factors for implementing these processes. A consensus emerged that CKD screening coupled with risk stratification and treatment should be implemented immediately for high-risk persons and that this should ideally occur in primary or community care settings with tailoring to the local context.
引用
- Shlipak MG, Tummalapalli SL, Boulware LE, et al. The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2020. PMID: 33127436. doi:10.1016/j.kint.2020.10.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。